Hangzhou Alltest Biotech Co., Ltd. (688606.SS)
CNY 67.11
(0.1%)
CNY 67.11
(0.1%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 754.69 Million | 3.38 Billion | 1.87 Billion | 1.13 Billion | 241.33 Million | 184.18 Million |
| Cost of Revenue | 380.66 Million | 1.35 Billion | 839.93 Million | 201.56 Million | 91.01 Million | 68.34 Million |
| Gross Profit | 374.03 Million | 2.03 Billion | 1.03 Billion | 933.99 Million | 150.31 Million | 115.84 Million |
| Operating Expenses | 156.57 Million | 398.98 Million | 163.73 Million | 108.07 Million | 66.09 Million | 50.95 Million |
| Selling, General and Administrative Expenses | 92.54 Million | 166.05 Million | 60.67 Million | 36.3 Million | 26.25 Million | 12.23 Million |
| Research and Development Expenses | 121.16 Million | 207.29 Million | 95.46 Million | 55.11 Million | 35.92 Million | 30.93 Million |
| Other Expenses | -57.14 Million | 25.62 Million | 7.59 Million | 16.66 Million | 3.9 Million | 7194.02 |
| Cost and Expenses | 543.11 Million | 1.75 Billion | 1 Billion | 309.63 Million | 157.1 Million | 119.3 Million |
| Operating Income | 211.58 Million | 1.39 Billion | 896.74 Million | 792.72 Million | 88.1 Million | 62.53 Million |
| Interest Expense | 1.45 Million | 2.17 Million | 668.76 Thousand | 18.6 Million | 604 Thousand | 436.2 Thousand |
| Income Tax Expense | 17.15 Million | 196.43 Million | 129.84 Million | 112.43 Million | 9.53 Million | 6.11 Million |
| Earnings before Tax | 197.43 Million | 1.38 Billion | 895.52 Million | 791.66 Million | 87.95 Million | 62.54 Million |
| Net Income | 180.57 Million | 1.18 Billion | 765.68 Million | 679.22 Million | 78.41 Million | 56.42 Million |
| Earnings Per Share Basic | 2.28 | 15.14 | 9.60 | 8.51 | 0.98 | 1.43 |
| Earnings Per Share Diluted | 2.28 | 15.14 | 9.60 | 8.51 | 0.98 | 1.43 |
| Weighted Average Shares Outstanding | 79.2 Million | 78.24 Million | 79.77 Million | 79.77 Million | 79.77 Million | 39.45 Million |
| Weighted Average Shares Outstanding (Diluted) | 79.2 Million | 78.24 Million | 79.77 Million | 79.77 Million | 79.77 Million | 39.45 Million |
| Gross Margin | 0.50 | 0.60 | 0.55 | 0.82 | 0.62 | 0.63 |
| EBIT Margin | 0.33 | 0.52 | 0.49 | 0.75 | 0.36 | 0.39 |
| Profit Margin | 0.24 | 0.35 | 0.41 | 0.60 | 0.32 | 0.31 |
| EBITDA | 249.76 Million | 1.41 Billion | 915.17 Million | 829.94 Million | 92.87 Million | 66.01 Million |
| Earnings Before Tax Margin | 0.28 | 0.41 | 0.48 | 0.70 | 0.37 | 0.34 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 221.52 Million | 196.58 Million | 199.92 Million | 754.67 Million | 194.74 Million | 172.09 Million |
| Cost of Revenue | 95.03 Million | 78.69 Million | 99.7 Million | 386.54 Million | 94.87 Million | 84.56 Million |
| Gross Profit | 126.48 Million | 117.89 Million | 100.21 Million | 368.13 Million | 99.86 Million | 87.53 Million |
| Operating Expenses | 50.18 Million | 47.4 Million | 48.71 Million | 546.08 Million | 115.24 Million | 59.16 Million |
| Selling, General and Administrative Expenses | 63.8 Million | 16.17 Million | 24.3 Million | - | -3.35 Million | 52.09 Million |
| Research and Development Expenses | 22.34 Million | 26 Million | 23.15 Million | - | 31.47 Million | 23.81 Million |
| Other Expenses | -35.95 Million | -10.67 Million | -171.69 Thousand | -546.08 Million | -115.24 Million | 14.78 Million |
| Cost and Expenses | 145.22 Million | 126.09 Million | 148.41 Million | 546.08 Million | 115.24 Million | 143.72 Million |
| Operating Income | 84.73 Million | 94.72 Million | 47.32 Million | 208.59 Million | 79.49 Million | 38.02 Million |
| Interest Expense | 105.33 Thousand | 128.28 Thousand | 132.55 Thousand | 1.45 Million | 290.9 Thousand | 379.74 Thousand |
| Income Tax Expense | 10.15 Million | 13.1 Million | 2.51 Million | 17.15 Million | 3.44 Million | 7.28 Million |
| Earnings before Tax | 84.16 Million | 91.99 Million | 47.15 Million | 194.45 Million | 79.48 Million | 37.7 Million |
| Net Income | 73.64 Million | 79.09 Million | 44.78 Million | 180.57 Million | 79.01 Million | 30.38 Million |
| Earnings Per Share Basic | 0.92 | 0.99 | 0.56 | - | 0.97 | 0.39 |
| Earnings Per Share Diluted | 0.92 | 0.99 | 0.56 | - | 0.99 | 0.39 |
| Weighted Average Shares Outstanding | 79.88 Million | 79.88 Million | 79.98 Million | 79.2 Million | 79.22 Million | 78.24 Million |
| Weighted Average Shares Outstanding (Diluted) | 79.88 Million | 79.88 Million | 79.98 Million | 79.2 Million | 79.22 Million | 78.24 Million |
| Gross Margin | 0.57 | 0.60 | 0.50 | 0.49 | 0.51 | 0.51 |
| EBIT Margin | 0.38 | 0.40 | 0.30 | - | 0.21 | 0.29 |
| Profit Margin | 0.33 | 0.40 | 0.22 | 0.24 | 0.41 | 0.18 |
| EBITDA | 84.27 Million | 78.25 Million | 60.74 Million | - | 40.6 Million | 49.94 Million |
| Earnings Before Tax Margin | 0.38 | 0.48 | 0.24 | 0.28 | 0.41 | 0.22 |
BAF
688050
FQVTF
EXXRF
MVI
BQST